Search - tctmd.com

Displaying 301 - 320 of 468

Sort: Relevancy | Date

Presentation TCT 2013

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Presenter: Robert Gil

October 29, 2013

Presentation TCT 2013

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

Presenter: Yelin Zhao

October 29, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Presenter: Bo Xu

October 27, 2013

News Industry News

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

October 22, 2013

News Industry News

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

October 21, 2013

News Daily News

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Jason Kahn

September 27, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Industry News

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

August 06, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Industry News

Micell Technologies Receives CE Mark Approval for MiStent SES

June 12, 2013

News Daily News

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

L.A. McKeown

June 07, 2013

Advertisement

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

MiStent SES Shown to be Unique in Clinical Setting

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

SES Show Advantage Over ZES, PES for Diabetic Patients

Micell Technologies Receives CE Mark Approval for MiStent SES

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content